NovaBay Pharmaceuticals News

NovaBay Pharmaceuticals | D: Filing D

Jun 28 15:22 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Garlikov Julie

May 30 21:33 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Freiman Paul E.

May 30 21:33 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sit Swan

May 30 21:28 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director WU MIJIA

May 30 21:28 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zheng Yenyou

May 30 21:23 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zheng Yongxiang

May 30 21:18 ET

NovaBay Pharmaceuticals | D: Filing D

Apr 5 12:28 ET

NovaBay Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)

Feb 14 14:58 ET

NovaBay Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Altium Capital Management, LP EIN:(4.99%),Altium Growth Fund, LP EIN:(4.99%), etc.

Feb 13 17:31 ET

NovaBay Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(9.99%),Sander Gerber(9.99%)

Feb 6 11:57 ET

NovaBay Pharmaceuticals | D: Filing D

Jan 4 00:00 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Freiman Paul E.

Jun 13, 2023 17:04 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Garlikov Julie

Jun 13, 2023 17:04 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zheng Yenyou

Jun 13, 2023 17:03 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zheng Yongxiang

Jun 13, 2023 17:02 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sit Swan

Jun 13, 2023 17:02 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director WU MIJIA

Jun 13, 2023 17:01 ET

NovaBay Pharmaceuticals | D: Filing D

May 18, 2023 17:15 ET

NovaBay Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Freiman Paul E.

May 15, 2023 18:54 ET